Gadski RA - Search Results

1

Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA.

Strnad J, Hamilton AE, Beavers LS, Gamboa GC, Apelgren LD, Taber LD, Sportsman JR, Bumol TF, Sharp JD, Gadski RA. Strnad J, et al. Among authors: gadski ra. Cancer Res. 1989 Jan 15;49(2):314-7. Cancer Res. 1989. PMID: 2463074

2

In vivo selection of human tumor cells resistant to monoclonal antibody-Vinca alkaloid immunoconjugates.

Starling JJ, Maciak RS, Hinson NA, Hoskins J, Laguzza BC, Gadski RA, Strnad J, Rittmann-Grauer L, DeHerdt SV, Bumol TF, et al. Starling JJ, et al. Among authors: gadski ra. Cancer Res. 1990 Dec 1;50(23):7634-40. Cancer Res. 1990. PMID: 1979247

3

Expression cloning of a human brain neuropeptide Y Y2 receptor.

Gehlert DR, Beavers LS, Johnson D, Gackenheimer SL, Schober DA, Gadski RA. Gehlert DR, et al. Among authors: gadski ra. Mol Pharmacol. 1996 Feb;49(2):224-8. Mol Pharmacol. 1996. PMID: 8632753

4

Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites.

Statnick MA, Schober DA, Gackenheimer S, Johnson D, Beavers L, Mayne NG, Burnett JP, Gadski R, Gehlert DR. Statnick MA, et al. Brain Res. 1998 Nov 9;810(1-2):16-26. doi: 10.1016/s0006-8993(98)00855-5. Brain Res. 1998. PMID: 9813224

5

Cloning and characterization of Rhesus monkey neuropeptide Y receptor subtypes.

Gehlert DR, Yang P, George C, Wang Y, Schober D, Gackenheimer S, Johnson D, Beavers LS, Gadski RA, Baez M. Gehlert DR, et al. Among authors: gadski ra. Peptides. 2001 Mar;22(3):343-50. doi: 10.1016/s0196-9781(01)00336-9. Peptides. 2001. PMID: 11287088

6

Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.

Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffman JA, Smiley DL, Chance RE, Lundell I, Larhammar D. Gehlert DR, et al. Mol Pharmacol. 1996 Jul;50(1):112-8. Mol Pharmacol. 1996. PMID: 8700103

7

Synthesis of 4 alpha-(2-propenyl)-5,6-secocholestan-3 alpha-ol, a novel B-ring seco analog of the hypocholesterolemic agent 4 alpha-(2-propenyl)-5 alpha-cholestan-3 alpha-ol.

Lin HS, Rampersaud AA, Richett ME, Beavers LS, McClure DB, Gadski RA. Lin HS, et al. Among authors: gadski ra. Steroids. 1998 Apr;63(4):202-7. doi: 10.1016/s0039-128x(98)00004-x. Steroids. 1998. PMID: 9589554

8

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes.

Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, Rafaeloff-Phail R, Seng T, Suter TM, Sluka JP, Ravussin E, Gadski RA, Caro JF. Statnick MA, et al. Among authors: gadski ra. Int J Exp Diabetes Res. 2000;1(2):81-8. doi: 10.1155/edr.2000.81. Int J Exp Diabetes Res. 2000. PMID: 11469400 Free PMC article.

9

Synthesis and in vitro biological activity of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha,12 alpha-diol, a 12alpha-hydroxyl analog of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha-ol: the latter is a potent activator of the low-density lipoprotein receptor promoter.

Lin HS, Rampersaud AA, Beavers LS, McClure DB, Gardner AJ, Eacho PI, Foxworthy PS, Gadski RA. Lin HS, et al. Among authors: gadski ra. Steroids. 1999 Oct;64(10):735-41. doi: 10.1016/s0039-128x(99)00053-7. Steroids. 1999. PMID: 10498032

10

[125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors.

Gehlert DR, Schober DA, Gackenheimer SL, Beavers L, Gadski R, Lundell I, Larhammar D. Gehlert DR, et al. Peptides. 1997;18(3):397-401. doi: 10.1016/s0196-9781(96)00346-4. Peptides. 1997. PMID: 9145427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters